Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
Date:10/24/2011

72.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/media.htm

Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors

Cell Therapeutics, Inc.Condensed Consolidated Statements of Operations(In thousands, except for per share amounts)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Revenues:License and contract revenue$
-$
-$
-$
319Total revenues---319Operating expenses:Research and development7,5305,10126,98219,375Selling, general and administrative7,7607,89325,29739,378Total operating expenses15,29012,99452,27958,753Loss from operations(15,290)(12,994)(52,279)(58,434)Other income (expense):Investment and other income (expense), net29(23)54240Interest expense(204)(385)(855)(1,948)Amortization of debt discount and issuance costs(129)(166)(436)(600)Foreign exchange gain (loss)(1,133)1,000(56)(300)Debt conversion expense---(2,031)Net loss before noncontrolling interest(16,727)(12,568)(53,572)(63,073)Noncontrolling interest6546179149Net loss attributable to CTI(16,662)(12,522)(53,393)(62,924)Dividends and deemed dividends on preferred stock(13,023)(3,085)(49,817)(50,519)Net loss attributable to CTI common shareholders$ (29,685)$ (15,607)$
(103,210)$
(113,443)Basic and diluted net loss per common share $
(0.16)$
(0.13)$
(0.62)$
(1.03)Shares used in calculation of basic and diluted184,997118,591165,724109,874Balance Sheet Data:(amounts in thousands)September 30,December 31,20112010(unaudited)Cash and cash equivalents $
45,212$
22,649Working capital19,096(14,165)Total assets62,85053,592Convertible debt12,42922,308Accumulated deficit(1,696,917)(1,576,64
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
2. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
8. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
9. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
10. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Follow us on LinkedIn ... available in abundance in nature. These natural bio-based ... as shells of crustaceans. The significant commercial interest ... the high percentage of nitrogen present compared to ... industries owing to its exclusive properties such as ...
(Date:9/22/2014)... Invisible Sentinel Inc., a life-sciences company ... beverage industries, announced today that its first-in-class Veriflow® ... agreement by Enartis, a global provider of specialty ... Group company headquartered in Trecate, Italy, will distribute ... global markets for their own in-winery use in ...
(Date:9/22/2014)... September 22, 2014 FierceBiotech today announced ... held biotechnology companies of 2014. FierceBiotech editors John ... selecting this year’s winners. Those selected are identified ... in the industry. , "It's always a ... of Fierce 15 companies," said Carroll. "This year in ...
(Date:9/22/2014)... Olso, Norway (PRWEB) September 22, 2014 ... convenient new parcel and pallet measuring device ... ScanTape™ eliminates manual data entry, offering greater ease ... time savings that result can significantly enhance productivity—an ... in industries where processing volume equals profits. ...
Breaking Biology Technology:Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 2Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 3Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2ScanTape™ Handheld Dimensioner Increases Processing Volume 2
... occasion of World Kidney Day, Kibow Biotech, Inc. is ... for the worldwide maintenance of healthy kidney function among ... In addition, Kibow Biotech, Inc. would also like to ... approvals for conducting human clinical trials with its patented, ...
... brain is a black box. A complex circuitry of ... workings of a computer chip. But while computer processors ... line, neural circuits are impenetrable masses. Think tumbleweed. ... developed a technique for unraveling these masses. Through a ...
... Colo.Physicists at the National,Institute of Standards and ... microwaves communicate with,a vibrating mechanical component 1,000 ... experiments. The microscopic,apparatus is a new tool ... of a relatively large object at the,smallest ...
Cached Biology Technology:Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease 2Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease 3Web-crawling the brain 2Web-crawling the brain 3NIST electromechanical circuit sets record beating microscopic 'drum' 2NIST electromechanical circuit sets record beating microscopic 'drum' 3
(Date:9/21/2014)... the University of California, San Diego, have developed a ... control the activity of genes based on sequences of ... its application to human embryonic cells in a paper ... , "All of our cells have the same blueprint, ... John Whitaker, lead author of the report. "Skin cells ...
(Date:9/19/2014)... it the Jimmy Durante of dinosaurs a ... profile. The new dinosaur, named Rhinorex condrupus ... and Brigham Young University, lived in what is ... the Late Cretaceous period. , Rhinorex, which translates ... a close relative of other Cretaceous hadrosaurs like ...
(Date:9/19/2014)... are a species which over thousands of years has adapted ... a substance that makes the cold dangerous for you. , ... albidus , and the cold provoking substance, called nonylphenol, comes ... Nonylphenol is suspected of being a endocrine disruptor, but when ... the worm,s ability to protect the cells in its body ...
Breaking Biology News(10 mins):Program predicts placement of chemical tags that control gene activity 2New hadrosaur noses into spotlight 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3
... Efforts to understand how the aging process affects the ... and older adults. "Everybody ages differently. By looking ... vascular health, we begin to understand that preventable factors ... State University psychology doctoral student Andrew Bender, lead author ...
... London have found a new therapeutic target to combat ... Cellular and Molecular Life Sciences , revealed tiny organelles ... findings could lead to potential therapies for millions of ... Knight who led the research at Queen Mary,s School ...
... 2012 Researchers at the Institute of Bioengineering and ... institute, have developed a miniaturized biochip for investigating the ... recently in Nano Today , this new technology ... In a tumor, CSCs form a small and ...
Cached Biology News:WSU researchers say genes and vascular risk modify effects of aging on brain and cognition 2WSU researchers say genes and vascular risk modify effects of aging on brain and cognition 3IBN's Droplet Array sheds light on drug-resistant cancer stem cells 2IBN's Droplet Array sheds light on drug-resistant cancer stem cells 3
...
... Apoptosis is an evolutionarily conserved form of ... process. The central component of this ... called caspases. These enzymes participate in ... in response to pro-apoptotic signals and result ...
... adapted Sf9 derivative for high-yield protein expression ... are derived from a high-yielding clone of ... serum-free TriEx Insect Cell Medium, these cells ... yields by either baculovirus infection or transfection ...
... against a partial recombinant MAK. ... a.a) partial recombinant protein with GST tag. ... Accession: BC039825 Protein ... 154235, GeneID: 4117 ...
Biology Products: